Study of Low Carbohydrate Enteral Nutrition in Patients With Bacterial Septic Shock
NCT03343041 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-11-26
Summary
This pilot study aims to test the tolerability of low-carbohydrate enteral nutrition in patients with bacterial septic shock.
Conditions
- Bacterial Sepsis
Interventions
- DIETARY_SUPPLEMENT
-
low-carbohydrate nutrition
low-carbohydrate enteral nutrition
- DIETARY_SUPPLEMENT
-
Standard enteral nutrition
standard enteral nutrition
Sponsors & Collaborators
-
Yale University
lead OTHER
Principal Investigators
-
Andrew Wang, MD PhD · Yale School of Medicine Department of Rheumatology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-08
- Primary Completion
- 2022-01-31
- Completion
- 2022-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effects of Enteral Nutrition Content on Disease Progression in Sepsis Patients
NCT06943326 ·Status: RECRUITING
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Impact of a Procalcitonin Testing and Treatment Algorithm on Antibiotic Use and Outcomes in the Pediatric Intensive Care Unit
NCT03440918 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
NCT00604214 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis
NCT03333304 ·Status: COMPLETED ·Phase: NA
-
Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children
NCT03441126 ·Status: COMPLETED
-
Study of Early Enteral Dextrose in Sepsis
NCT03454087 ·Status: COMPLETED ·Phase: NA
-
Investigate the Activity of Endotoxin in Severe Sepsis
NCT01957254 ·Status: TERMINATED
-
Beta-Lactam InfusioN Group Study
NCT03213990 ·Status: COMPLETED ·Phase: NA
-
The Distribution of Plasma Drug Concentrations of Beta-lactam Antibiotics in Intensive Care Unit Patients
NCT02446392 ·Status: COMPLETED
-
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Effect of Immune Modulating Enteral Nutrition Formula
NCT05186480 ·Status: UNKNOWN ·Phase: NA
-
Anti-inflammatory Effects of Enriched Enteral Nutrition During Human Experimental Endotoxemia
NCT01100996 ·Status: COMPLETED ·Phase: NA
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Lactate Kinetics in Septic Shock
NCT05349370 ·Status: RECRUITING ·Phase: NA
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock
NCT03461900 ·Status: COMPLETED ·Phase: NA
-
Epidemiology of Septic Shock in Medical or Polyvalent ICU in the North-East Region of France
NCT01903746 ·Status: TERMINATED
-
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury
NCT02664753 ·Status: TERMINATED ·Phase: PHASE3
-
Utility of Sodium Lactate Infusion During Septic Shock
NCT03528213 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Rapid Administration of Carnitine in sEpsis
NCT01665092 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
NCT02317549 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation
NCT00372502 ·Status: COMPLETED ·Phase: NA
-
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: A Pilot Feasibility Study
NCT03340805 ·Status: COMPLETED ·Phase: PHASE1
-
Interstitial Fluid Composition in Patients With Septic Versus Non-septic Shock: an Exploratory Pilot Study
NCT05039151 ·Status: COMPLETED